Brokers Offer Predictions for Cardinal Health Q3 Earnings

Cardinal Health, Inc. (NYSE:CAH) – Analysts at Zacks Research boosted their Q3 2026 earnings per share (EPS) estimates for shares of Cardinal Health in a research note issued to investors on Thursday, December 5th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $2.40 for the quarter, up from their prior forecast of $2.35. The consensus estimate for Cardinal Health’s current full-year earnings is $7.82 per share. Zacks Research also issued estimates for Cardinal Health’s FY2026 earnings at $8.65 EPS and FY2027 earnings at $9.20 EPS.

Cardinal Health (NYSE:CAH) last announced its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. During the same period last year, the business posted $1.73 EPS. Cardinal Health’s revenue for the quarter was down 4.3% on a year-over-year basis.

A number of other equities analysts have also recently commented on the company. Argus raised their target price on Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. Evercore ISI lifted their price objective on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research note on Thursday, August 15th. Barclays lifted their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, UBS Group lifted their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $124.58.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $122.76 on Monday. The business has a 50-day moving average of $116.29 and a 200 day moving average of $107.72. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $126.23. The stock has a market capitalization of $29.71 billion, a price-to-earnings ratio of 23.88, a price-to-earnings-growth ratio of 1.57 and a beta of 0.61.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health’s payout ratio is 39.30%.

Institutional Investors Weigh In On Cardinal Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Eastern Bank purchased a new stake in Cardinal Health in the third quarter valued at approximately $25,000. Cultivar Capital Inc. purchased a new stake in Cardinal Health in the second quarter valued at approximately $27,000. Frazier Financial Advisors LLC lifted its stake in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new stake in Cardinal Health in the second quarter valued at approximately $29,000. Finally, Hara Capital LLC purchased a new stake in Cardinal Health in the third quarter valued at approximately $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.